Skip Navigation



IJE Advance Access published online on April 21, 2007
International Journal of Epidemiology, doi:10.1093/ije/dym070
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
36/2/263    most recent
dym070v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Ebrahim, S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Ebrahim, S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published by Oxford University Press on behalf of the International Epidemiological Association © The Author 2007; all rights reserved.

Editor's Choice

Prostate cancer, Cochrane, Durkheim and Beer Lao

Shah Ebrahim

E-mail: shah.ebrahim@lshtm.ac.uk

The first 10% of the full text of this article appears below.

There are many things to worry about as we get older. Women have had to cope with gynaecological cancer screening for decades but for men, prostate cancer screening is the latest worry on the scene for British men of a certain age, 50+ to be exact, as a new trial of prostate cancer screening is now underway in many areas of the country. In other countries, prostate specific antibody (PSA) screening is already part of the ‘well-man’ (or is that ‘worried-man’?) screening battery, putting you closer to a prostate biopsy than you might want. In this issue we reprint . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?